This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Buy These 4 Stocks With Solid Net Profit Margin to Maximize Returns
by Anirudha Bhagat
Let's take a look at four stocks, CPRX, GAMB, ORN and BWAY, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.
Here's What Could Help Brainsway (BWAY) Maintain Its Recent Price Strength
by Zacks Equity Research
Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Is the Options Market Predicting a Spike in Brainsway Stock?
by Zacks Equity Research
Investors need to pay close attention to Brainsway stock based on the movements in the options market lately.
Wall Street Analysts Believe Brainsway (BWAY) Could Rally 30.98%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Brainsway (BWAY) points to a 31% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength?
by Zacks Equity Research
Brainsway (BWAY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Are Medical Stocks Lagging Brainsway (BWAY) This Year?
by Zacks Equity Research
Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Brainsway (BWAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Does Brainsway (BWAY) Have the Potential to Rally 43.88% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Brainsway (BWAY) points to a 43.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Earnings Estimates Moving Higher for Brainsway (BWAY): Time to Buy?
by Zacks Equity Research
Brainsway (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts See a 41.31% Upside in Brainsway (BWAY): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 41.3% in Brainsway (BWAY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
BWAY Drops 15% in Four Days: How to Play the Stock Before Earnings?
by Harshit Gupta
BWAY stock continues to struggle near its IPO price despite growth. With rising revenues, global expansion and valuation concerns, is it a buy, hold or sell before earnings?
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Brainsway (BWAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include SB Financial Group, First Community, StoneX Group, Byrna Technologies and BrainsWay
by Zacks Equity Research
SB Financial Group, First Community, StoneX Group, Byrna Technologies and BrainsWay have been highlighted in this Screen of The Week article.
5 Stocks With Recent Price Strength to Enhance Your Portfolio
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are SBFG, FCCO, SNEX, BYRN, BWAY.
Zacks.com featured highlights include Mission Produce, Accel Entertainment, BrainsWay and First Bank
by Zacks Equity Research
Mission Produce, Accel Entertainment, BrainsWay and First Bank have been highlighted in this Screen of The Week article.
Zacks.com featured highlights include Bridgewater Bancshares, Eastern Bankshares and BrainsWay
by Zacks Equity Research
Bridgewater Bancshares, Eastern Bankshares and BrainsWay have been highlighted in this Screen of The Week article.
4 Top-Ranked Solid Net Profit Margin Stocks to Boost Portfolio Returns
by Anirudha Bhagat
Let us take a look at four top-ranked stocks, AVO, ACEL, BWAY and FRBA, with stellar net profit margins that can help create a winning portfolio.
3 Top-Ranked Breakout Stocks to Buy Now: BWB, EBC, BWAY
by Tirthankar Chakraborty
Bridgewater Bancshares, Eastern Bankshares and BrainsWay have been selected as the breakout stocks for today.
Outbrain (OB) and Brainsway (BWAY) Are Aggressive Growth Stocks
by Brian Bolan
Two More Stocks for your Aggressive Growth Stock Radar Screen.
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Brainsway (BWAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Brainsway Ltd. Sponsored ADR (BWAY) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Brainsway (BWAY) Moves 8.0% Higher: Will This Strength Last?
by Zacks Equity Research
Brainsway (BWAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Bear of the Day: Baxter (BAX)
by David Bartosiak
The recent earnings trend has been troubling. Can the company turn it around next year?